Efficacy of platelet-rich fibrin in frontal fibrosing alopecia

Study of efficacy, satisfaction and safety of Platelet-rich fibrin (PRF) in the treatmentof Frontal Fibrosing Alopecia: A single blind controlled randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140624018210N14

Enrollment

Registered

2025-06-11

Start date

2025-07-23

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frontal Fibrosing Alopecia. Follicular lichen planus

Interventions

Intervention 1: Intervention group: Prf + standard. Intervention 2: Control group: standard.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with Frontal Fibrosing Alopecia (FFA) confirmed by clinical examination. Patient’s cooperation in undergoing therapeutic interventions and attending all treatment and follow-up sessions. Patient’s adherence to post-intervention recommendations.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Perifollicular erythema and scaling. Timepoint: 3months and 6 months. Method of measurement: Dermatoscopy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Behrangi

Iran University of Medical Sciences

behrangi.e@iums.ac.ir+98 21 8871 7272

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026